These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

715 related items for PubMed ID: 17427117

  • 1. [Surveillance colonoscopy in ulcerative colitis patients in Germany].
    Kaltz B, Bokemeyer B, Hoffmann J, Porschen R, Rogler G, Schmiegel W.
    Z Gastroenterol; 2007 Apr; 45(4):325-31. PubMed ID: 17427117
    [Abstract] [Full Text] [Related]

  • 2. [Carcinogenesis in ulcerative colitis-associated colon cancer and surveillance colonoscopy].
    Kawa K, Hida N, Ohda Y, Watanabe K, Miwa H, Matsumoto T.
    Nihon Rinsho; 2005 May; 63(5):809-14. PubMed ID: 15881174
    [Abstract] [Full Text] [Related]

  • 3. Is dysplasia visible during surveillance colonoscopy in patients with ulcerative colitis?
    Blonski W, Kundu R, Lewis J, Aberra F, Osterman M, Lichtenstein GR.
    Scand J Gastroenterol; 2008 May; 43(6):698-703. PubMed ID: 18569987
    [Abstract] [Full Text] [Related]

  • 4. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation.
    Hurlstone DP, Sanders DS, Lobo AJ, McAlindon ME, Cross SS.
    Endoscopy; 2005 Dec; 37(12):1186-92. PubMed ID: 16329015
    [Abstract] [Full Text] [Related]

  • 5. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis.
    Markowitz J, McKinley M, Kahn E, Stiel L, Rosa J, Grancher K, Daum F.
    Am J Gastroenterol; 1997 Nov; 92(11):2001-6. PubMed ID: 9362180
    [Abstract] [Full Text] [Related]

  • 6. [Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia].
    Raithel M, Weidenhiller M, Schwab D, Müller S, Hahn EG.
    Z Gastroenterol; 2001 Oct; 39(10):861-75. PubMed ID: 11605156
    [Abstract] [Full Text] [Related]

  • 7. Screening and surveillance of ulcerative colitis.
    Axon AT.
    Gastrointest Endosc Clin N Am; 1997 Jan; 7(1):129-45. PubMed ID: 8995118
    [Abstract] [Full Text] [Related]

  • 8. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E, Kordek R, Biernat W, Tureaud J, Liberski PP, Majumdar AP.
    Hepatogastroenterology; 1997 Jan; 44(14):435-40. PubMed ID: 9164515
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Low grade dysplasia in ulcerative colitis].
    Herfarth H, Messmann H.
    Z Gastroenterol; 2003 Apr; 41(4):351-3. PubMed ID: 12695943
    [No Abstract] [Full Text] [Related]

  • 12. Results of cancer surveillance in ulcerative colitis.
    Suzuki K, Muto T, Shinozaki M, Higuchi Y, Sawada T, Saito Y.
    J Gastroenterol; 1995 Nov; 30 Suppl 8():40-2. PubMed ID: 8563886
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Is routine endoscopic monitoring for prevention of carcinoma in ulcerative colitis of value?].
    Hempen I, Singer MV.
    Z Gastroenterol; 1995 Jan; 33(1):26-8. PubMed ID: 7886984
    [No Abstract] [Full Text] [Related]

  • 17. Chronic ulcerative colitis and Crohn's disease as precancerous conditions: what is the role of colonoscopy?
    Ekbom A.
    Endoscopy; 1995 Jan; 27(1):50-3; discussion 62-3. PubMed ID: 7601036
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.